Loading page
Loading page
Loading substance route
These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
Chronic use can be considered moderately addictive with a high potential for abuse and is capable of causing psychological dependence among certain users. Compulsive redosing is commonly reported, and cravings may occur upon cessation of regular use.
Withdrawal effects may occur if usage is suddenly stopped after dependence develops, though specific physical withdrawal symptoms have not been documented for this substance.
The exact toxic dosage is unknown. The toxicity and long-term health effects have not been studied in any scientific context due to the substance's extremely short history of human usage. Given its claimed equipotency to methamphetamine, it may be similarly difficult to dose safely.
Abuse of amphetamine-class compounds at high dosages for prolonged periods can result in stimulant psychosis presenting with paranoia, hallucinations, or delusions. Approximately 5-15% of users who develop amphetamine psychosis fail to recover completely, though antipsychotic medications effectively resolve symptoms of acute episodes. Psychosis very rarely arises from therapeutic or occasional use.
3-Fluoroamphetamine emerged as part of a wave of designer fluorinated amphetamine compounds that gained popularity in the late 2000s as research chemical alternatives to traditionally available stimulants. This series includes related compounds such as 2-FA, 2-FMA, 3-FEA, and 4-FA. The substance…
Classified as a controlled substance as of October 2015.
As of December 2024, not explicitly scheduled under French drug laws. Possession is technically legal but exists in a regulatory grey area.
Classified as a Schedule 3 Class C controlled substance due to its status as an amphetamine analogue under New Zealand drug scheduling.
Classified as a controlled drug. Possession, production, supply, and importation are all prohibited.
Not explicitly scheduled at the federal level but may be prosecuted under the Federal Analogue Act (21 U.S.C. § 813) as structurally similar to amphetamine. This provision applies only when the substance is intended for human consumption, treating it as equivalent to a Schedule I or II controlled substance.
Listed in the government decree on substances, preparations, and plants considered to be narcotic drugs.
Controlled under the Neue-psychoaktive-Stoffe-Gesetz (New Psychoactive Substances Act) since November 26, 2016. Production, import for market placement, administration to others, and trading are punishable offenses. Possession is prohibited but not subject to criminal penalty.
Specifically named as a controlled substance under Verzeichnis E of Swiss narcotics legislation.
Controlled as a Class A substance under the amphetamine analogue clause of the Misuse of Drugs Act 1971. Class A classification carries the most severe penalties under UK drug law.
9 sources cited